Under the research collaboration, serum and urine samples collected by Hirosaki investigators from well-characterized patient and control populations in Japan, will be examined. The glycan analysis will be
The company expects to maintain sufficient reserves of oncology drug supplies and multiple manufacturing facilities approved by the FDA. Spectrum president and chief executive officer Rajesh Shrotriya said
Xarelto (rivaroxaban tablet) is indicated for the prevention of stroke and systemic embolism in patients with AF, in whom anticoagulation is appropriate. Bayer Corporate Affairs head Doug Grant
NutriVerus powder offers essential vitamins and minerals, antioxidants, glyconutrients, stabilized rice bran and organic fruits and vegetables. Mannatech CEO and chief science officer Robert Sinnott said NutriVerus powder
Pristima suite is the fully integrated preclinical and vivarium management solution that connects to enterprise quality & compliance management processes. Xybion Preclinical Solutions vice president Carlos Frade said
As per the agreement, AstraZeneca will take over Ardea for $32 per share, also adding RDEA3170, a next-generation selective URAT1 inhibitor currently in Phase I development, to its
The US label changes are the result of discussions with the FDA, following cases of heart attacks and strokes in patients who took Gilenya. The drug is contraindicated
The investment is also aimed to set up a multiproduct facility in Visakhapatnam, India, and to upgrade existing facilities, reports Business Standard. The multiproduct manufacturing facility is expected
The acquisition, which is expected to close within 30 days, will merge XenneX into LifeMap Sciences. The deal is expected to integrate GeneCards and PanDaTox in a centralized
The companies have also been requesting the government to upgrade the basic technical teaching systems, for better trained human source to manage the sector on long term sustainable
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.